Companies / BOC Sciences / Pascolizumab
BOC Sciences

Pascolizumab | BOC Sciences

Pascolizumab is a humanized monoclonal antibody directed against IL-4. Pascolizumab inhibits upstream and downstream events associated with asthma, including TH2 cell activation and immunoglobulin E production. Pascolizumab is investigated for the treatment of asthma.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.